Targeting Residual Disease in Oncogene-Driven NSCLC

被引：0
|
作者：
McCoach, C. E. [1 ]
Merrick, D. T. [1 ]
Aisner, D. L. [1 ]
Bunn, P. A. [1 ]
Camdige, D. R. [1 ]
Heasley, L. E. [1 ]
Doebele, R. C. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2017.06.064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1546 / S1546
页数：1
相关论文
共 50 条
  • [41] PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Addeo, Alfredo
    Banna, Giuseppe Luigi
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S287 - S289
  • [42] Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Metro, Giulio
    Di Maio, Massimo
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S294 - S296
  • [43] Parallels between oncogene-driven cardiac hyperplasia and heart regeneration in zebrafish
    Pfefferli, Catherine
    Bonvin, Marylene
    Grepper, Dogan
    Robatel, Steve
    Konig, Desiree
    Lischer, Heidi E. L.
    Bruggmann, Remy
    Jazwinska, Anna
    [J]. DEVELOPMENT, 2023, 150 (12):
  • [44] USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer
    Fraile, Julia M.
    Manchado, Eusebio
    Lujambio, Amaia
    Quesada, Victor
    Campos-Iglesias, Diana
    Webb, Thomas R.
    Lowe, Scott W.
    Lopez-Otin, Carlos
    Freije, Jose M. P.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (10) : 4164 - 4175
  • [45] Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Metro, Giulio
    Di Maio, Massimo
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S290 - S293
  • [46] Treatment of oncogene-driven non-small cell lung cancer
    Kastelijn, Elisabeth A.
    de Langen, Adrianus J.
    Peters, Bas J. M.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (03) : 300 - 307
  • [47] PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
    Addeo, Alfredo
    Banna, Giuseppe Luigi
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S283 - S286
  • [48] The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis
    Magnus, Nathalie
    Meehan, Brian
    Gamier, Delphine
    Hashemi, Maryam
    Montermini, Laura
    Lee, Tae Hoon
    Milsom, Chloe
    Pawlinski, Rafal
    Ohlfest, John
    Anderson, G. Mark
    Mackman, Nigel
    Rak, Janusz
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 454 (02) : 262 - 268
  • [49] Managing the Isolated Central Nervous System Progression in Patients With Oncogene-Driven Metastatic NSCLC: Does Circulating Tumor DNA Add to Management?
    Li, Tianhong
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : 314 - 316
  • [50] Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer
    Vokes, Natalie I.
    Pan, Kelsey
    Le, Xiuning
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345